Model
Edge
CytomX Therapeutics Inc.
0001886426
Filing Type
4
Filing Date
6/16/2022
Updated
6/17/22, 10:04 AM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership